azathioprine has been researched along with Stunted Growth in 19 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
"Guidelines for treatment of ulcerative colitis in children have been created by the working group of the Japanese Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Japanese Society for Pediatric Inflammatory Bowel Disease." | 2.43 | [Guidelines for treatment of ulcerative colitis in children]. ( Tomomasa, T, 2005) |
"Diagnostic criteria for CD, ulcerative colitis (UC), and indeterminate colitis (IC) were defined." | 1.33 | Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease. ( Bonova, O; Dedek, P; Frühauf, P; Havlickova, A; Janatova, T; Jimramovsky, F; Klimova, L; Klusacek, D; Kocourkova, D; Kolek, A; Kotalova, R; Maly, J; Marx, D; Nevoral, J; Petro, R; Petru, O; Plasilova, I; Pozler, O; Schreierova, I; Seidl, Z; Sekyrova, I; Semendak, N; Stanek, J; Sulakova, A; Sykora, J; Toukalkova, L; Travnickova, R; Volf, V; Zahradnicek, L; Zenisková, I, 2006) |
" CsA dosage remained unchanged in the range of 200 mg/m2/day; CsA whole blood trough level was 120 to 130 ng/mL throughout the years." | 1.28 | Long-term results of cyclosporin A therapy in children. ( Bökenkamp, A; Brodehl, J; Hoyer, PF; Offner, G, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (47.37) | 18.7374 |
1990's | 6 (31.58) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Verkasalo, M | 1 |
Tomomasa, T | 1 |
Pozler, O | 1 |
Maly, J | 1 |
Bonova, O | 1 |
Dedek, P | 1 |
Frühauf, P | 1 |
Havlickova, A | 1 |
Janatova, T | 1 |
Jimramovsky, F | 1 |
Klimova, L | 1 |
Klusacek, D | 1 |
Kocourkova, D | 1 |
Kolek, A | 1 |
Kotalova, R | 1 |
Marx, D | 1 |
Nevoral, J | 1 |
Petro, R | 1 |
Petru, O | 1 |
Plasilova, I | 1 |
Seidl, Z | 1 |
Sekyrova, I | 1 |
Semendak, N | 1 |
Schreierova, I | 1 |
Stanek, J | 1 |
Sykora, J | 1 |
Sulakova, A | 1 |
Toukalkova, L | 1 |
Travnickova, R | 1 |
Volf, V | 1 |
Zahradnicek, L | 1 |
Zenisková, I | 1 |
Burren, CP | 1 |
Jones, CL | 1 |
Francis, DM | 1 |
Powell, HR | 1 |
Walker, RG | 1 |
Hokken-Koelega, AC | 1 |
Van Zaal, MA | 1 |
de Ridder, MA | 1 |
Wolff, ED | 1 |
De Jong, MC | 1 |
Donckerwolcke, RA | 1 |
De Muinck Keizer-Schrama, SM | 1 |
Drop, SL | 1 |
Markowitz, J | 1 |
Grancher, K | 1 |
Rosa, J | 1 |
Aiges, H | 1 |
Daum, F | 1 |
Sarna, S | 1 |
Sipilä, I | 1 |
Rönnholm, K | 1 |
Koistinen, R | 1 |
Holmberg, C | 1 |
Potter, DE | 1 |
Holliday, MA | 1 |
Wilson, CJ | 1 |
Salvatierra, O | 1 |
Belzer, FO | 1 |
Kasper, H | 1 |
Offner, G | 3 |
Brandis, M | 1 |
Brodehl, J | 3 |
Krohn, HP | 1 |
Pichlmayr, R | 1 |
Tidow, G | 1 |
Scott, JR | 1 |
Bökenkamp, A | 1 |
Hoyer, PF | 1 |
Aschendorff, C | 1 |
Schrago, R | 1 |
Miescher, PA | 1 |
Williams, GM | 1 |
Lee, HM | 1 |
Hume, DM | 1 |
Cicognani, A | 1 |
Mei, V | 1 |
Pirazzoli, P | 1 |
Tassoni, P | 1 |
Collina, A | 1 |
Tazzari, R | 1 |
Cacciari, E | 1 |
Saenger, P | 1 |
Wiedemann, E | 1 |
Schwartz, E | 1 |
Korth-Schutz, S | 1 |
Lewy, JE | 1 |
Riggio, RR | 1 |
Rubin, AL | 1 |
Stenzel, KH | 1 |
New, MI | 1 |
Bell, MJ | 1 |
Martin, LW | 1 |
Gonzales, LL | 1 |
McEnery, PT | 1 |
West, CD | 1 |
Rinawi, F | 1 |
Rosenbach, Y | 1 |
Assa, A | 1 |
Shamir, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Nutritional Status and Body Composition in Children With Inflammatory Bowel Disease: A Prospective Cohort Study[NCT02704026] | 72 participants (Actual) | Observational | 2015-07-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for azathioprine and Stunted Growth
Article | Year |
---|---|
[Drug therapy and nutrition therapy of a young patient with Crohn disease].
Topics: Adjuvants, Immunologic; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal | 2003 |
[Guidelines for treatment of ulcerative colitis in children].
Topics: Azathioprine; Child; Colitis, Ulcerative; Contraindications; Cyclosporins; Growth Disorders; Humans; | 2005 |
1 trial available for azathioprine and Stunted Growth
Article | Year |
---|---|
Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation.
Topics: Azathioprine; Child; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Stu | 1996 |
16 other studies available for azathioprine and Stunted Growth
Article | Year |
---|---|
Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Aminosalicylic Acids; Azathioprine; Child; Child, | 2006 |
Renal transplantation in young children.
Topics: Azathioprine; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; | 1995 |
Growth after renal transplantation in prepubertal children: impact of various treatment modalities.
Topics: Azathioprine; Body Height; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Fema | 1994 |
Growth failure in pediatric inflammatory bowel disease.
Topics: Adolescent; Adrenal Cortex Hormones; Anthropometry; Azathioprine; Body Height; Child; Colitis, Ulcer | 1993 |
Alternate-day steroids in children after renal transplantation.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Child; Dactinomycin; Graft Rejection; Growth Disorde | 1975 |
[Enteritis regionalis (Crohn's disease) (proceedings)].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Amyloidosis; Arthritis; Azathioprine; Child; Child | 1976 |
[Kidney transplantation in children at Hannover from 1970 to 1977 (author's transl)].
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Female; Growth Disorders; Humans; Kidney Transpla | 1979 |
Fetal growth retardation associated with maternal administration of immunosuppressive drugs.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Depression, Chemical; Female; Fetal Diseases; | 1977 |
Long-term results of cyclosporin A therapy in children.
Topics: Adolescent; Antihypertensive Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Female; Fo | 1992 |
Growth after renal transplantation: an update.
Topics: Adolescent; Azathioprine; Body Height; Bone Development; Child; Child, Preschool; Cyclosporine; Fema | 1991 |
[The treatment of dermatomyositis].
Topics: Adolescent; Adrenocorticotropic Hormone; Alpha-Globulins; Antibodies, Antinuclear; Antimetabolites; | 1974 |
Renal transplants in children.
Topics: 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Azathioprine; Child; Epiphyses, Slipped; F | 1969 |
[Body height increase and secretion of somatotropin in children with variously treated hephrotic syndromes].
Topics: Adrenocorticotropic Hormone; Azathioprine; Body Height; Child; Child, Preschool; Chronic Disease; Fe | 1973 |
Somatomedin and growth after renal transplantation.
Topics: Adolescent; Age Determination by Skeleton; Azathioprine; Body Height; Bone Development; Child; Gluco | 1974 |
Alternate-day single-dose prednisone therapy: a method of reducing steroid toxicity.
Topics: Adolescent; Adult; Azathioprine; Bacterial Infections; Bone Diseases; Cataract; Child; Child, Presch | 1972 |
Ustekinumab for Resistant Pediatric Crohn Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Crohn Disease; Drug Administration Schedule; Drug Mo | 2016 |